Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2025 Standout
Adipokines: masterminds of metabolic inflammation
2024 Standout
Works of John Xu being referenced
Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function
2017
Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| John Xu | 391 | 250 | 165 | 21 | 538 | |
| C. P. Bastl | 231 | 122 | 201 | 20 | 571 | |
| Komuraiah Myakala | 263 | 183 | 171 | 17 | 559 | |
| Fotini Adamidou | 393 | 202 | 92 | 29 | 618 | |
| Ryo Kodera | 360 | 185 | 169 | 16 | 632 | |
| Jun Honjo | 261 | 200 | 237 | 19 | 622 | |
| R. Roßkamp | 401 | 183 | 201 | 31 | 635 | |
| Wim Wilpshaar | 355 | 337 | 205 | 14 | 628 | |
| Michael E. Cobble | 304 | 142 | 122 | 17 | 487 | |
| Yasutaka Miyachi | 285 | 217 | 229 | 25 | 639 | |
| Linqiang Ma | 282 | 246 | 197 | 29 | 623 |
All Works
Loading papers...